Prevalence, comorbidity and impact of irritable bowel syndrome in Norway

Scandinavian Journal of Gastroenterology

Volumn 41, Issue 6, 2006, Pages 650-656

  Vandvik, Per Olav ^a,b   Lydersen, Stian ^b   Farup, Per G ^a,b  

^a Innlandet Hospital Health Authority   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Epidemiology; Fibromyalgia; Functional bowel disease; Health resources; Health survey; Mood disorder; Rome II criteria

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BLOATING; COMORBIDITY; CONSTIPATION; CONSULTATION; DIARRHEA; FEMALE; FIBROMYALGIA; GENERAL PRACTITIONER; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; IRRITABLE COLON; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MENTAL STRESS; MOOD DISORDER; MUSCULOSKELETAL DISEASE; NORWAY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOLOGIST; QUESTIONNAIRE; SYMPTOM; WORK DISABILITY;

ADULT; AGED; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; FIBROMYALGIA; HEALTH RESOURCES; HEALTH SERVICES; HEALTH SURVEYS; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; MOOD DISORDERS; NORWAY; PREVALENCE; QUESTIONNAIRES; SEX FACTORS; SOMATOFORM DISORDERS;

EID: 33745700395     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520500442542     Document Type: Article

References (22)

1. Hungin AP, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects. Aliment Pharmacol Ther 2003;17:643-50.
2. El Serag HB, Olden K, Bjorkman D. Health-related quality of life among persons with irritable bowel syndrome: a systematic review. Aliment Pharmacol Ther 2002;16:1171-85.
3. Badia X, Mearin F, Balboa A, Baro E, Caldwell E, Cucala M, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. Pharmacoeconomics 2002;20:749-58.
4. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-56.
5. Levy RL, Von Korff M, Whitehead WE, Stang P, Saunders K, Jhingran P, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001;96:3122-9.
6. Maxton DG, Morris J, Whorwell PJ. More accurate diagnosis of irritable bowel syndrome by the use of "non-colonic" symptomatology. Gut 1991;32:784-6.
7. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45 Suppl 2:II43-7.
8. Boyce PM, Koloski NA, Talley NJ. Irritable bowel syndrome according to varying diagnostic criteria: are the new Rome II criteria unnecessarily restrictive for research and practice? Am J Gastroenterol 2000;95:3176-83.
9. Strand BH, Dalgard OS, Tambs K, Rognerud M. Measuring the mental health status of the Norwegian population: a comparison of the instruments SCL-25, SCL-10, SCL-5 and MHI-5 (SF-36). Nord J Psychiatry 2003;57:113-8.
10. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004;20:1195-203.
11. Whitehead WE, Bosmajian L, Zonderman AB, Costa PT, Jr, Schuster MM. Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples. Gastroenterology 1988;95:709-14.
12. Drossman DA, McKee DC, Sandler RS, Mitchell CM, Cramer EM, Lowman BC, et al. Psychosocial factors in the irritable bowel syndrome. A multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701-8.
13. Osterberg E, Blomquist L, Krakau I, Weinryb RM, Asberg M, Hultcrantz R. A population study on irritable bowel syndrome and mental health. Scand J Gastroenterol 2000;35:264-8.
14. Palsson OS, Whitehead WE. The growing case for hypnosis as adjunctive therapy for functional gastrointestinal disorders. Gastroenterology 2002;123:2132-5.
15. Thompson WG, Irvine EJ, Pare P, Ferrazzi S, Rance L. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225-35.
16. Mearin F, Badia X, Balboa A, Baro E, Caldwell E, Cucala M, et al. Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol 2001;36:1155-61.
17. Saito YA, Locke GR, Talley NJ, Zinsmeister AR, Fett SL, Melton LJ, III. A comparison of the Rome and Manning criteria for case identification in epidemiological investigations of irritable bowel syndrome. Am J Gastroenterol 2000;95:2816-24.
18. Thompson WG, Heaton KW, Smyth GT, Smyth C. Irritable bowel syndrome: the view from general practice. Eur J Gastroenterol Hepatol 1997;9:689-92.
19. Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003;17:841-51.
20. Talley NJ, Boyce PM, Jones M. Predictors of health care seeking for irritable bowel syndrome: a population based study. Gut 1997;41:394-8.
21. Søgaard AJ, Selmer R, Bjertness E, Thelle D. The Oslo Health Study: the impact of self-selection in a large, population-based survey. Int J Equity Health 2004;3:3. Available from: http://www.equityhealthj.com/content/3/ 1/3.
22. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.